Meda Pharmaceuticals USA

Home About Meda Pharmaceuticals Products Join Media Center Healthcare Professionals Contact Us

All Products      


Products
The Meda Pharmaceutical product portfolio is focused primarily on respiratory, allergy, central nervous system, cough-cold, musculoskeletal, and rheumatology products.

The product information presented here is intended for use in the United States only. Other countries may have different regulatory requirements and review practices that may require referencing different information.

To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc.
at 1-800-526-3840 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Product Name
(active ingredient)
Prescribing InformationProduct Web Site
Astelin® Nasal Spray, 137 mcg
(azelastine hydrochloride)
Astelin Prescribing Information www.astelin.com
Astepro® Nasal Spray, 0.1% and 0.15%
(azelastine hydrochloride)
Astepro Prescribing Information www.astepro.com
Butisol Sodium® Tablets, 30 mg and 50 mg and Oral Solution, 30 mg/5 mL
(butabarbital sodium)
Butisol Sodium Tablet and Oral Solution Prescribing Information  
Cesamet® Capsules
(nabilone)
Cesamet Prescribing Information – 20 Count Bottle
Cesamet Prescribing Information – 50 Count Bottle
www.cesamet.com
Demadex® Tablets 5 mg, 10 mg, 20 mg, and 100 mg
(torsemide)
Demadex Tablet Prescribing Information 
Depen® (Penicillamine Tablets, USP) Titratable Tablets
(penicillamine)
Depen Tablet Prescribing Information  
Edluar™ Sublingual Tablets, 5 mg and 10 mg
(zolpidem tartrate)
Edluar Sublingual Tablet Prescribing Information www.edluar.com
Felbatol® Tablets, 400 mg and 600 mg, and Oral Suspension, 600 mg/5 mL
(felbamate)
Felbatol Tablet and Oral Suspension Prescribing Information www.felbatol.com
Lufyllin® Tablets, 200 mg and 400 mg
(dyphylline)
Lufyllin Tablet Prescribing Information  
Lufyllin® GG Oral Solution, 100 mg/15 mL
(dyphylline)
Lufyllin GG Oral Solution Prescribing Information 
Onsolis™ (fentanyl buccal soluble film)
(fentanyl citrate)
Onsolis Prescribing Information www.onsolis.com
Optivar® 0.05% Ophthalmic Solution
(azelastine hydrochloride)
Optivar Prescribing Information www.optivar.com
Organidin® NR Tablets, 200 mg and Liquid, 100 mg/5 mL
(guaifenesin)
Organidin NR Tablet and Liquid Prescribing Information 
Ryna-12® Tablets and Ryna-12S® Suspension
(phenylephrine tannate, pyrilamine tannate)
Ryna-12 Tablet and Ryna-12S Suspension Prescribing Information 
Ryna-12X® Tablets and Suspension
(phenylephrine tannate, pyrilamine tannate, guaifenesin)
Ryna-12X Tablet and Suspension Prescribing Information 
Rynatan® Pediatric Suspension (Reformulated)
(phenylephrine tannate, chlorpheniramine tannate)
Rynatan Pediatric Suspension (Reformulated) Prescribing Information 
Rynatan® Chewable Pediatric Tablets
(phenylephrine tannate, chlorpheniramine tannate)
Rynatan Chewable Pediatric Tablet Prescribing Information 
Rynatan® Tablets
(phenylephrine tannate, chlorpheniramine tannate)
Rynatan Tablet Prescribing Information 
Rynatuss® Tablets
(carbetapentane tannate, phenylephrine tannate,
chlorpheniramine tannate, ephedrine tannate)
Rynatuss Tablet Prescribing Information  
Sina-12X® Tablets and Suspension
(phenylephrine tannate, guaifenesin)
Sina-12X Tablet and Suspension Prescribing Information 
Soma® Tablets, 250 mg and 350 mg
(carisoprodol)
Soma Tablet Prescribing Information www.soma250.com
Tussi-12® Tablets (Reformulated) and Tussi-12®S Suspension (Reformulated)
(carbetapentane tannate, pyrilamine tannate, phenylephrine tannate)
Tussi-12 Tablet and Tussi-12S Suspension Prescribing Information 
Tussi-12D® Tablets and Tussi-12D®S Suspension
(carbetapentane tannate, pyrilamine tannate, phenylephrine tannate)
Tussi-12D Tablet and Tussi-12DS Suspension Prescribing Information 

You will need Adobe® Reader.

To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc.
at 1-800-526-3840 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.



Privacy Policy